From SARS to COVID-19: A Previously Unknown SARS- Related Coronavirus (SARS-CoV-2) of Pandemic Potential Infecting Humans - Call for a One Health Approach

Overview

Journal One Health

Specialty Infectious Diseases

Date 2020 Mar 21

PMID 32195311

Citations 176

Authors

Mohamed E El Zowalaty

Josef D Jarhult

Affiliations

Soon will be listed here.

Abstract

Human coronaviruses continue to pose a threat to human health. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease-2019 (COVID-19), an acute respiratory disease marked the third introduction of a highly pathogenic coronavirus into the human population in the twenty-first century. This recent emergence of a previously unknown coronavirus in China leads to huge impacts on humans globally. Covid-19 is a challenge to global public health. Here, we discuss the COVID-19 outbreak in a one health context, highlighting the need for the implementation of one health measures and practices to improve human health and reduce the emergence of pandemic viruses.

Citing Articles

Tracing Emergence of SARS-CoV-2 Variants: Insights from Comprehensive Assessment Using Reverse Transcription Polymerase Chain Reaction and Whole Genome Sequencing.

Na D, Hong Y, Lee C, Kim M Microorganisms. 2025; 13(2).

PMID: 40005678 PMC: 11858702. DOI: 10.3390/microorganisms13020311.

Bayesian spatio-temporal modeling of severe acute respiratory syndrome in Brazil: A comparative analysis across pre-, during, and post-COVID-19 eras.

Souza Bulhoes R, Pimentel J, Rodrigues P Infect Dis Model. 2025; 10(2):466-476.

PMID: 39834649 PMC: 11743096. DOI: 10.1016/j.idm.2024.12.010.

[Good practices in epidemiological surveillance for the sustainability of measles, rubella, and congenital rubella syndrome elimination in El Salvador, 2019-2023Boas práticas de vigilância epidemiológica para a sustentabilidade da eliminação do...].

Barrientos Llovet A, Ruballo de Gutierrez M, Hernandez Martinez A, Jimenez R, Chacon Aguirre E, Rivera Rosales D Rev Panam Salud Publica. 2024; 48:e118.

PMID: 39687249 PMC: 11648102. DOI: 10.26633/RPSP.2024.118.

Neutrophil-to-Lymphocyte Ratio and Cytokine Profiling as Predictors of Disease Severity and Survival in Unvaccinated COVID-19 Patients.

Mendez Rodriguez M, Ponciano-Gomez A, Campos-Aguilar M, Tapia-Sanchez W, Duarte-Martinez C, Romero-Herrera J Vaccines (Basel). 2024; 12(8).

PMID: 39203987 PMC: 11360520. DOI: 10.3390/vaccines12080861.

Realising a global One Health disease surveillance approach: insights from wastewater and beyond.

Hill R, Stentiford G, Walker D, Baker-Austin C, Ward G, Maskrey B Nat Commun. 2024; 15(1):5324.

PMID: 38909028 PMC: 11193741. DOI: 10.1038/s41467-024-49417-4.

References

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Du L, Jiang S . Middle East respiratory syndrome: current status and future prospects for vaccine development. Expert Opin Biol Ther. 2015; 15(11):1647-51. PMC: 4636333. DOI: 10.1517/14712598.2015.1092518. View

Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch H, Widmer A, Neher R . 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. Swiss Med Wkly. 2020; 150:w20203. DOI: 10.4414/smw.2020.20203. View

Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H, Becker S . Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1967-76. DOI: 10.1056/NEJMoa030747. View

Hui D, Zumla A . Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019; 33(4):869-889. PMC: 7127569. DOI: 10.1016/j.idc.2019.07.001. View

Rodriguez-Morales A, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P . Going global - Travel and the 2019 novel coronavirus. Travel Med Infect Dis. 2020; 33:101578. PMC: 7128681. DOI: 10.1016/j.tmaid.2020.101578. View

Sautto G, Kirchenbaum G, Ross T . Towards a universal influenza vaccine: different approaches for one goal. Virol J. 2018; 15(1):17. PMC: 5785881. DOI: 10.1186/s12985-017-0918-y. View

Menachery V, Yount Jr B, Sims A, Debbink K, Agnihothram S, Gralinski L . SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A. 2016; 113(11):3048-53. PMC: 4801244. DOI: 10.1073/pnas.1517719113. View

10.

. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

11.

Paraskevis D, Kostaki E, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S . Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020; 79:104212. PMC: 7106301. DOI: 10.1016/j.meegid.2020.104212. View

12.

Zheng Z, Lu Y, Short K, Lu J . One health insights to prevent the next HxNy viral outbreak: learning from the epidemiology of H7N9. BMC Infect Dis. 2019; 19(1):138. PMC: 6371560. DOI: 10.1186/s12879-019-3752-6. View

13.

Zhang H, El Zowalaty M . DNA-based influenza vaccines as immunoprophylactic agents toward universality. Future Microbiol. 2015; 11(1):153-64. DOI: 10.2217/fmb.15.110. View

14.

Wu F, Zhao S, Yu B, Chen Y, Wang W, Song Z . A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269. PMC: 7094943. DOI: 10.1038/s41586-020-2008-3. View

15.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

16.

Osterhaus A, Fouchier R, Rimmelzwaan G . Towards universal influenza vaccines?. Philos Trans R Soc Lond B Biol Sci. 2011; 366(1579):2766-73. PMC: 3146782. DOI: 10.1098/rstb.2011.0102. View

17.

Ma M, Wang G, Anderson B, Bi Z, Lu B, Wang X . Evidence for Cross-species Influenza A Virus Transmission Within Swine Farms, China: A One Health, Prospective Cohort Study. Clin Infect Dis. 2018; 66(4):533-540. PMC: 5848305. DOI: 10.1093/cid/cix823. View

18.

Okba N, Raj V, Widjaja I, GeurtsvanKessel C, de Bruin E, Chandler F . Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections. Emerg Infect Dis. 2019; 25(10):1868-1877. PMC: 6759241. DOI: 10.3201/eid2510.190051. View

19.

Dawood F, Jain S, Finelli L, Shaw M, Lindstrom S, Garten R . Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 360(25):2605-15. DOI: 10.1056/NEJMoa0903810. View

20.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View